Pharmaceutical firm Vertex strikes $105m cash and equity deal with university IP-based Crispr Therapeutics.

Commerzbank has co-led a round for the insurance management app that also featured Rocket Internet and several corporate-backed venture firms.

Backed by Novo, Johnson & Johnson, Novartis and Pfizer, the immuno-oncology drug developer was previously reported in April 2015 to be seeking a $105m offering.

The e-commerce group has sold its stakes in e-commerce company Netretail and price comparison service Heureka to investment firm Rockaway Capital.

Novo and Lundbeck-backed Acacia Pharma has postponed a $230m initial public offering in London as the healthcare IPO market continues to slow.

Growth equity firm Acton Capital Partners has closed a $200m fund that counts publishing group Hubert Burda, from which it spun out, as an anchor investor.